Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Climb Bio, Inc. | 170,000 | reported | 31 Oct 2022 | tx 2+340,000 |
| Neurogene Inc. | 25,000 | reported | 08 Jun 2023 | tx 2+50,000 |
| Jade Biosciences, Inc. | 23,017 | reported | 29 Apr 2025 | tx 1+23,017 |
| ALDER BIOPHARMACEUTICALS INC | 0 | reported | 22 Oct 2019 | tx 8+467,526−467,526 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 Apr 2025 | GRANT_AWARD | Jade Biosciences, Inc. | 23,017 | 0.00 USD | deriv |
| 08 Jun 2023 | GRANT_AWARD | Neurogene Inc. | 25,000 | 0.00 USD | deriv |
| 31 Oct 2022 | GRANT_AWARD | Climb Bio, Inc. | 170,000 | 0.00 USD | deriv |
| 12 May 2022 | GRANT_AWARD | Neurogene Inc. | 25,000 | 0.00 USD | deriv |
| 27 Jan 2022 | GRANT_AWARD | Climb Bio, Inc. | 170,000 | 0.00 USD | deriv |
| 22 Oct 2019 | GRANT_AWARD | ALDER BIOPHARMACEUTICALS INC | 11,684 | 0.00 USD | |
| 22 Oct 2019 | TENDER | ALDER BIOPHARMACEUTICALS INC | 16,092 | 18.00 USD | |
| 22 Oct 2019 | OTHER | ALDER BIOPHARMACEUTICALS INC | 300,000 | 0.00 USD | deriv |
| 22 Oct 2019 | OTHER | ALDER BIOPHARMACEUTICALS INC | 150,000 | 0.00 USD | deriv |
| 25 Apr 2019 | SALE | ALDER BIOPHARMACEUTICALS INC | 1,434 | 13.67 USD | |
| 23 Apr 2019 | GRANT_AWARD | ALDER BIOPHARMACEUTICALS INC | 5,842 | 0.00 USD | |
| 06 Feb 2019 | GRANT_AWARD | ALDER BIOPHARMACEUTICALS INC | 150,000 | 0.00 USD | deriv |
| 16 Apr 2018 | GRANT_AWARD | ALDER BIOPHARMACEUTICALS INC | 300,000 | 0.00 USD | deriv |